Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation time

被引:37
作者
Lundberg, BB [1 ]
Mortimer, BC [1 ]
Redgrave, TG [1 ]
机构
[1] UNIV WESTERN AUSTRALIA, DEPT PHYSIOL, NEDLANDS, WA 6907, AUSTRALIA
关键词
lipid emulsion; drug carrier; hydrophilicity; in vivo clearance; organ uptake;
D O I
10.1016/0378-5173(96)04456-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Submicron-sized lipid emulsions possess many favourable properties as drug-carriers like biocompatibility, physical stability and ease of preparation. The use of colloidal carriers is, however, hampered by their rapid clearance from the circulation. In the present study, this problem was tackled by coating the emulsion droplets with polyethylene glycol modified phosphatidylethanolamine (PEG-PE). Physical stability was obtained by using a mixture of phosphatidylcholine and polysorbate 80 as emulsifying agent. Sonicated preparations with the standard composition; triolein (TO): dipalmitoyl phosphatidylcholine (DPPC): polysorbate 80: PEG-PE at mass ratios of 2: 1: 0.4: 0.1 exhibited a mean particle size of 44 nm (by quasi-elastic light scattering) and an excellent physical stability. In vivo plasma clearance data were obtained by intravenous injection of emulsions into mice. Coating of the emulsion droplets with PEG-PE gave a considerable increase in circulation lifetime. A further notable effect was obtained when the cosurfactant polysorbate 80 was introduced into the system, apparently as a result of decreased particle size. Lipid emulsions with the standard composition showed first order kinetics during 6 h with a circulation half-life of about 3 h. Phospholipid transition temperature and emulsion particle size were found to be important factors while the clearance rate was essentially independent of lipid dose.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 23 条
[1]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[2]   LIPOSOMES CONTAINING SYNTHETIC LIPID DERIVATIVES OF POLY(ETHYLENE GLYCOL) SHOW PROLONGED CIRCULATION HALF-LIVES INVIVO [J].
ALLEN, TM ;
HANSEN, C ;
MARTIN, F ;
REDEMANN, C ;
YAUYOUNG, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (01) :29-36
[3]   LIPOSOMES FOR THE SUSTAINED DRUG RELEASE INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1029 (01) :91-97
[4]   LIPID EMULSIONS AS DRUG DELIVERY SYSTEMS [J].
DAVIS, SS ;
WASHINGTON, C ;
WEST, P ;
ILLUM, L ;
LIVERSIDGE, G ;
STERNSON, L ;
KIRSH, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 :75-88
[5]   PROCESSING OF DIFFERENT LIPOSOME MARKERS AFTER INVITRO UPTAKE OF IMMUNOGLOBULIN-COATED LIPOSOMES BY RAT-LIVER MACROPHAGES [J].
DERKSEN, JTP ;
MORSELT, HWM ;
SCHERPHOF, GL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 931 (01) :33-40
[6]   POLYSTYRENE-POLY(ETHYLENE GLYCOL) (PS-PEG2000) PARTICLES AS MODEL SYSTEMS FOR SITE-SPECIFIC DRUG-DELIVERY .2. THE EFFECT OF PEG SURFACE-DENSITY ON THE IN-VITRO CELL-INTERACTION AND IN-VIVO BIODISTRIBUTION [J].
DUNN, SE ;
BRINDLEY, A ;
DAVIS, SS ;
DAVIES, MC ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (07) :1016-1022
[7]   THE ORGAN UPTAKE OF INTRAVENOUSLY ADMINISTERED COLLOIDAL PARTICLES CAN BE ALTERED USING A NON-IONIC SURFACTANT (POLOXAMER-338) [J].
ILLUM, L ;
DAVIS, SS .
FEBS LETTERS, 1984, 167 (01) :79-82
[8]  
ILLUM L, 1989, INT J PHARM, V52, P221
[9]   DELIVERY OF NOVEL THERAPEUTIC AGENTS IN TUMORS - PHYSIOLOGICAL BARRIERS AND STRATEGIES [J].
JAIN, RK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (08) :570-576
[10]   PREPARATION OF DRUG-CARRIER EMULSIONS STABILIZED WITH PHOSPHATIDYLCHOLINE-SURFACTANT MIXTURES [J].
LUNDBERG, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (01) :72-75